Brendan Frey is an internationally acclaimed entrepreneur and scientist. Brendan has made contributions in the fields of deep learning, genomic medicine, and information technology. He is the co-author of over 200 papers. Brendan was a pioneer in developing AI systems that accurately predict normal and pathological cell and genome biology, facilitating biomedical breakthroughs. This work led to the discovery of new biology, the founding of Deep Genomics in 2015, the first AI system for predicting pathogenic mutations and identifying therapeutic targets, and the development of new therapeutic candidates for patients with genetic disorders. Brendan is Professor of Engineering and Medicine at the University of Toronto, a Fellow of the American Association for the Advancement of Science, a Fellow of the Institute of Electrical and Electronic Engineers, a Senior Fellow of the Canadian Institute for Advanced Research, and a Fellow of the Royal Society of Canada. Brendan has advised the leadership of Microsoft Research on machine learning and deep learning technology, and was a member of its Technical Advisory Board. He has held numerous researcher and professor positions at the University of Illinois at Urbana-Champaign, Cambridge University in the United Kingdom, the Isaac Newton Institute for Mathematical Sciences and the University of Waterloo.